𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Minimum Required Vitamin D Level for Optimal Increase in Bone Mineral Density with Alendronate Treatment in Osteoporotic Women

✍ Scribed by Muneaki Ishijima; Yuko Sakamoto; Makoto Yamanaka; Akifumi Tokita; Keiichiro Kitahara; Haruka Kaneko; Hisashi Kurosawa


Publisher
Springer
Year
2009
Tongue
English
Weight
224 KB
Volume
85
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effects of 1 year of daily teriparatide
✍ Barbara M Misof; Eleftherios P Paschalis; StΓ©phane Blouin; Nadja Fratzl-Zelman; πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 163 KB πŸ‘ 1 views

## Abstract Anabolic treatment with teriparatide of postmenopausal osteoporotic patients previously treated with bisphosphonates is a new therapeutic approach. However, its effects on the bone mineralization density distribution (BMDD) are unknown. We studied paired transiliac bone biopsy samples t

The presence of a polymorphism at the tr
✍ Coleman Gross; T. Ross Eccleshall; Peter J. Malloy; Marie Luz Villa; Robert Marc πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 531 KB

We examined the association of bone mineral density (BMD) with a polymorphism in the gene encoding the vitamin D receptor (VOR) that causes a change in the predicted protein sequence. The polymorphism results from a C-to-T transition and creates an initiation codon (ATG) three codons proximal to a d